Xeloda is the trade name for Capecitabine. It is a chemotherapy drug that is used to treat breast cancer, gastric cancer, and colorectal cancer. It's often combined with docetaxel in the treatment of breast cancer. It is taken orally. Market growth is aided by factors such as rising cancer incidence and increased demand for target drug therapy. Furthermore, rising healthcare expenditures and increased government and private-sector investment in cancer treatment or assistance programs are expected to drive market growth. Patients have benefited from benefits such as improved access and availability in the form of the oral dose. Increased prescriptions of capecitabine in conjunction with docetaxel, pertuzumab, and trastuzumab to extend overall survival in metastatic breast cancer are also expected to fuel the segment's growth.This growth is primarily driven by Rising Prevalence of Cancer and Increasing Awareness and Spending on Healthcare.
Globally, a noticeable market trend is evident Development in Oncology Treatment Drugs. Major Players, such as Teva Pharmaceuticals, Inc. (Israel), Hoffmann-La Roche AG (Switzerland), Mylan N.V. (United States), Hikma Pharmaceuticals PLC (United Kingdom), Cipla Inc. (India), Dr. Reddy's Laboratories Ltd. (India), Fresenius SE & Co. KGaA (Germany), Intas Pharmaceuticals Limited (India), Sun Pharmaceutical Industries Limited and Torrent Pharmaceuticals (India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
February 2021 – Dr Reddy's Labs announced the launch of Capecitabine Tablets, USP a therapeutic equivalent generic version of Xeloda (capecitabine) Tablets approved by the US Food and Drug Administration (USFDA).
- Rising Prevalence of Cancer
- Increasing Awareness and Spending on Healthcare
- Development in Oncology Treatment Drugs
- Adverse Side Effects of Drugs
Increase Investment in R&D in Cancer Treatment and Various Governments Initiatives to Increase Awareness and Investment
Stringent Regulatory Factors
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis